[Form 4] CoreWeave, Inc. Insider Trading Activity

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

CoreWeave, Inc. insider trading report: A senior officer, the Chief Development Officer of CoreWeave, Inc. (CRWV), reported multiple transactions in Class A Common Stock dated 12/15/2025. The filing shows several conversions of Class B Common Stock into Class A Common Stock for the reporting person and various related trusts, followed by sales of Class A shares.

Shares were sold in multiple blocks at weighted average prices generally in the low-to-high $70s per share, with detailed price ranges disclosed between $72.08 and $79.69. The sales were executed under a Rule 10b5-1 trading plan that the reporting person adopted on September 2, 2025. After these transactions, the reporting person continues to hold significant Class A and Class B positions directly and through several family and trust entities, as reflected in the remaining beneficial ownership figures in Tables I and II.

Insider Trade Summary

Net Seller: 130,835 shares ($9,626,311)

Net Sell 34 txns

Insider McBee Brannin

Role Chief Development Officer

Sold 130,835 shs ($9.63M)

Type	Security	Shares	Price	Value
Conversion	Class B Common Stock	102,835	$0.00	--
Conversion	Class B Common Stock	25,000	$0.00	--
Conversion	Class B Common Stock	3,000	$0.00	--
Conversion	Class B Common Stock	1,000	$0.00	--
Conversion	Class B Common Stock	1,000	$0.00	--
Conversion	Class B Common Stock	25,000	$0.00	--
Conversion	Class B Common Stock	8,335	$0.00	--
Conversion	Class A Common Stock	102,835	$0.00	--
Conversion	Class A Common Stock	25,000	$0.00	--
Conversion	Class A Common Stock	3,000	$0.00	--
Conversion	Class A Common Stock	1,000	$0.00	--
Conversion	Class A Common Stock	1,000	$0.00	--
Conversion	Class A Common Stock	25,000	$0.00	--
Conversion	Class A Common Stock	8,335	$0.00	--
Sale	Class A Common Stock	41,709	$72.4924	$3.02M
Sale	Class A Common Stock	41,451	$73.6678	$3.05M
Sale	Class A Common Stock	11,728	$74.3739	$872K
Sale	Class A Common Stock	2,062	$75.5931	$156K
Sale	Class A Common Stock	1,544	$76.5727	$118K
Sale	Class A Common Stock	2,043	$78.2974	$160K
Sale	Class A Common Stock	2,298	$79.3819	$182K
Sale	Class A Common Stock	10,140	$72.4924	$735K
Sale	Class A Common Stock	10,077	$73.6678	$742K
Sale	Class A Common Stock	2,851	$74.3738	$212K
Sale	Class A Common Stock	502	$75.5935	$38K
Sale	Class A Common Stock	376	$76.5744	$29K
Sale	Class A Common Stock	496	$78.2977	$39K
Sale	Class A Common Stock	558	$79.3822	$44K
Sale	Class A Common Stock	1,208	$72.5225	$88K
Sale	Class A Common Stock	1,335	$73.729	$98K
Sale	Class A Common Stock	184	$74.5213	$14K
Sale	Class A Common Stock	109	$76.3515	$8K
Sale	Class A Common Stock	109	$78.8569	$9K
Sale	Class A Common Stock	55	$79.69	$4K

Holdings After Transaction: Class B Common Stock — 9,117,155 shares (Direct); Class B Common Stock — 4,191,020 shares (Indirect, Brannin J. McBee 2022 Irrevocable Trust); Class A Common Stock — 288,016 shares (Direct); Class A Common Stock — 25,000 shares (Indirect, Brannin J McBee 2022 Irrevocable Trust)

Footnotes (1)

Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee. The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager. The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary. The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.08 to $73.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.08 to $74.07, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.08 to $75.03, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.08 to $76.06, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.10 to $77.07, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.02 to $78.80, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.11 to $79.69, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.08 to $73.07, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.19 to $73.01, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.20 to $74.16, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.30 to $74.94, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.97 to $76.74, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.65 to $79.06, inclusive.

Form 4 Insider Transactions: What Each Field Means →

12/17/2025 - 08:11 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McBee Brannin

(Last)

(First)

(Middle)

C/O COREWEAVE, INC.

290 WEST MT. PLEASANT AVENUE, SUITE 4100

(Street)

LIVINGSTON

07039

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CoreWeave, Inc. [ CRWV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Development Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	12/15/2025		C		102,835	A	⁽¹⁾	288,016	D
Class A Common Stock	12/15/2025		C		25,000	A	⁽¹⁾	25,000	I	Brannin J McBee 2022 Irrevocable Trust⁽²⁾
Class A Common Stock	12/15/2025		C		3,000	A	⁽¹⁾	3,000	I	Canis Major 2024 Irrevocable Trust LLC⁽³⁾
Class A Common Stock	12/15/2025		C		1,000	A	⁽¹⁾	1,000	I	Canis Major 2025 Family Trust LLC⁽⁴⁾
Class A Common Stock	12/15/2025		C		1,000	A	⁽¹⁾	1,000	I	Canis Minor 2025 Family Trust LLC⁽⁵⁾
Class A Common Stock	12/15/2025		C		25,000	A	⁽¹⁾	25,000	I	Canis Major 2025 GRAT⁽⁶⁾
Class A Common Stock	12/15/2025		C		8,335	A	⁽¹⁾	8,335	I	Canis Minor 2025 GRAT⁽⁷⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		41,709	D	$72.4924⁽⁹⁾	246,307	D
Class A Common Stock	12/15/2025		S⁽⁸⁾		41,451	D	$73.6678⁽¹⁰⁾	204,856	D
Class A Common Stock	12/15/2025		S⁽⁸⁾		11,728	D	$74.3739⁽¹¹⁾	193,128	D
Class A Common Stock	12/15/2025		S⁽⁸⁾		2,062	D	$75.5931⁽¹²⁾	191,066	D
Class A Common Stock	12/15/2025		S⁽⁸⁾		1,544	D	$76.5727⁽¹³⁾	189,522	D
Class A Common Stock	12/15/2025		S⁽⁸⁾		2,043	D	$78.2974⁽¹⁴⁾	187,479	D
Class A Common Stock	12/15/2025		S⁽⁸⁾		2,298	D	$79.3819⁽¹⁵⁾	185,181	D
Class A Common Stock	12/15/2025		S⁽⁸⁾		10,140	D	$72.4924⁽¹⁶⁾	14,860	I	Brannin J McBee 2022 Irrevocable Trust⁽²⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		10,077	D	$73.6678⁽¹⁰⁾	4,783	I	Brannin J McBee 2022 Irrevocable Trust⁽²⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		2,851	D	$74.3738⁽¹¹⁾	1,932	I	Brannin J McBee 2022 Irrevocable Trust⁽²⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		502	D	$75.5935⁽¹²⁾	1,430	I	Brannin J McBee 2022 Irrevocable Trust⁽²⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		376	D	$76.5744⁽¹³⁾	1,054	I	Brannin J McBee 2022 Irrevocable Trust⁽²⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		496	D	$78.2977⁽¹⁴⁾	558	I	Brannin J McBee 2022 Irrevocable Trust⁽²⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		558	D	$79.3822⁽¹⁵⁾	0	I	Brannin J McBee 2022 Irrevocable Trust⁽²⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		1,208	D	$72.5225⁽¹⁷⁾	1,792	I	Canis Major 2024 Irrevocable Trust LLC⁽³⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		1,335	D	$73.729⁽¹⁸⁾	457	I	Canis Major 2024 Irrevocable Trust LLC⁽³⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		184	D	$74.5213⁽¹⁹⁾	273	I	Canis Major 2024 Irrevocable Trust LLC⁽³⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		109	D	$76.3515⁽²⁰⁾	164	I	Canis Major 2024 Irrevocable Trust LLC⁽³⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		109	D	$78.8569⁽²¹⁾	55	I	Canis Major 2024 Irrevocable Trust LLC⁽³⁾
Class A Common Stock	12/15/2025		S⁽⁸⁾		55	D	$79.69	0	I	Canis Major 2024 Irrevocable Trust LLC⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Class B Common Stock	⁽¹⁾	12/15/2025		C			102,835	⁽¹⁾	⁽¹⁾	Class A Common Stock	102,835	⁽¹⁾	9,117,155	D
Class B Common Stock	⁽¹⁾	12/15/2025		C			25,000	⁽¹⁾	⁽¹⁾	Class A Common Stock	25,000	⁽¹⁾	4,191,020	I	Brannin J. McBee 2022 Irrevocable Trust⁽²⁾
Class B Common Stock	⁽¹⁾	12/15/2025		C			3,000	⁽¹⁾	⁽¹⁾	Class A Common Stock	3,000	⁽¹⁾	351,000	I	Canis Major 2024 Irrevocable Trust LLC⁽³⁾
Class B Common Stock	⁽¹⁾	12/15/2025		C			1,000	⁽¹⁾	⁽¹⁾	Class A Common Stock	1,000	⁽¹⁾	117,600	I	Canis Major 2025 Family Trust LLC⁽⁴⁾
Class B Common Stock	⁽¹⁾	12/15/2025		C			1,000	⁽¹⁾	⁽¹⁾	Class A Common Stock	1,000	⁽¹⁾	131,000	I	Canis Minor 2025 Family Trust LLC⁽⁵⁾
Class B Common Stock	⁽¹⁾	12/15/2025		C			25,000	⁽¹⁾	⁽¹⁾	Class A Common Stock	25,000	⁽¹⁾	5,925,000	I	Canis Major 2025 GRAT⁽⁶⁾
Class B Common Stock	⁽¹⁾	12/15/2025		C			8,335	⁽¹⁾	⁽¹⁾	Class A Common Stock	8,335	⁽¹⁾	974,995	I	Canis Minor 2025 GRAT⁽⁷⁾

Explanation of Responses:

1. Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

2. The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee.

3. The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager.

4. The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

5. The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

6. The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.

7. The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee.

8. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.

9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.08 to $73.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.

10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.08 to $74.07, inclusive.

11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.08 to $75.03, inclusive.

12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.08 to $76.06, inclusive.

13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.10 to $77.07, inclusive.

14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.02 to $78.80, inclusive.

15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.11 to $79.69, inclusive.

16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.08 to $73.07, inclusive.

17. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.19 to $73.01, inclusive.

18. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.20 to $74.16, inclusive.

19. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.30 to $74.94, inclusive.

20. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.97 to $76.74, inclusive.

21. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.65 to $79.06, inclusive.

Remarks:

This Form 4 is Part 1 of 3 for this reporting person. Transactions by the reporting person reported on Table I are continued on Parts 2 and 3.

	/s/ Nisha Antony, as Attorney-in-Fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

[Form 4] CoreWeave, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Positive

Negative

Insider Trade Summary